Literature DB >> 21907086

Surgical approach to l-dopa-induced dyskinesias.

Tejas Sankar1, Andres M Lozano.   

Abstract

Many patients treated chronically with l-dopa for Parkinson disease (PD) become functionally disabled by l-dopa-induced dyskinesias (LID). Evolved from early empirical procedures, modern stereotactic surgical lesioning techniques and deep brain stimulation (DBS) can effectively treat LID while simultaneously improving the cardinal motor symptoms of PD. Here we review the common surgical targets used to treat LID, and compare their relative efficacy. We explain the anti-dyskinetic action of surgery at each of these targets based on evolving models of basal ganglia function. Finally, we discuss the appropriate selection of patients with LID for surgery and address relevant technical and management issues in these patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907086     DOI: 10.1016/B978-0-12-381328-2.00006-7

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  8 in total

1.  Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.

Authors:  Maryka Quik; Carla Campos; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

2.  Brain stimulation in neuropsychiatry.

Authors:  Gwenn S Smith; Shawn M McClintock; Mustafa Husain
Journal:  Int Rev Psychiatry       Date:  2011-10

Review 3.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

Review 4.  Basal Forebrain Impairment: Understanding the Mnemonic Function of the Septal Region Translates in Therapeutic Advances.

Authors:  Marian Tsanov
Journal:  Front Neural Circuits       Date:  2022-05-31       Impact factor: 3.342

5.  Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function.

Authors:  Maryka Quik; Archana Mallela; Matthew Chin; J Michael McIntosh; Xiomara A Perez; Tanuja Bordia
Journal:  Neurobiol Dis       Date:  2012-09-23       Impact factor: 5.996

6.  Improvement of Deep Brain Stimulation in Dyskinesia in Parkinson's Disease: A Meta-Analysis.

Authors:  Yun Liu; Feng Li; Hansheng Luo; Qiuguang He; Lifen Chen; Yuan Cheng; Wenbin Zhang; Zongyi Xie
Journal:  Front Neurol       Date:  2019-02-25       Impact factor: 4.003

7.  Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.

Authors:  Shi-Ying Fan; Kai-Liang Wang; Wei Hu; Robert S Eisinger; Alexander Han; Chun-Lei Han; Qiao Wang; Shimabukuro Michitomo; Jian-Guo Zhang; Feng Wang; Adolfo Ramirez-Zamora; Fan-Gang Meng
Journal:  Ann Clin Transl Neurol       Date:  2019-12-08       Impact factor: 4.511

Review 8.  Deep Brain Stimulation in Drug Addiction Treatment: Research Progress and Perspective.

Authors:  Rui Chang; Jionghong Peng; Yunfan Chen; Hailin Liao; Size Zhao; Ju Zou; Sijie Tan
Journal:  Front Psychiatry       Date:  2022-04-07       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.